Post-COVID-19 illness and associations with sex and gender

Abstract Background Post-COVID-19 syndromes have associated with female sex, but the pathophysiological basis is uncertain. Aim There are sex differences in myocardial inflammation identified using cardiac magnetic resonance (CMR) in post-COVID-19 patients, and in patient reported health outcomes fo...

Full description

Bibliographic Details
Main Authors: Kenneth Mangion, Andrew J. Morrow, Robert Sykes, Anna Kamdar, Catherine Bagot, George Bruce, Paul Connelly, Christian Delles, Vivienne B. Gibson, Lynsey Gillespie, Pauline Hall Barrientos, Vera Lennie, Giles Roditi, Naveed Sattar, David Stobo, Sarah Allwood-Spiers, Alex McConnachie, Colin Berry, CISCO-19 investigators
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-023-03412-7
_version_ 1827635671536238592
author Kenneth Mangion
Andrew J. Morrow
Robert Sykes
Anna Kamdar
Catherine Bagot
George Bruce
Paul Connelly
Christian Delles
Vivienne B. Gibson
Lynsey Gillespie
Pauline Hall Barrientos
Vera Lennie
Giles Roditi
Naveed Sattar
David Stobo
Sarah Allwood-Spiers
Alex McConnachie
Colin Berry
CISCO-19 investigators
author_facet Kenneth Mangion
Andrew J. Morrow
Robert Sykes
Anna Kamdar
Catherine Bagot
George Bruce
Paul Connelly
Christian Delles
Vivienne B. Gibson
Lynsey Gillespie
Pauline Hall Barrientos
Vera Lennie
Giles Roditi
Naveed Sattar
David Stobo
Sarah Allwood-Spiers
Alex McConnachie
Colin Berry
CISCO-19 investigators
author_sort Kenneth Mangion
collection DOAJ
description Abstract Background Post-COVID-19 syndromes have associated with female sex, but the pathophysiological basis is uncertain. Aim There are sex differences in myocardial inflammation identified using cardiac magnetic resonance (CMR) in post-COVID-19 patients, and in patient reported health outcomes following COVID-19 infection. Design This prospective study investigated the time-course of multiorgan injury in survivors of COVID-19 during convalescence. Methods Clinical information, blood biomarkers, and patient reported outcome measures were prospectively acquired at enrolment (visit 1) and 28–60 days post-discharge (visit 2). Chest computed tomography (CT) and CMR were performed at visit 2. Follow-up was carried out for serious adverse events, including death and rehospitalization. Results Sixty-nine (43%) of 159 patients recruited were female. During the index admission, females had a lower peak C-reactive protein (74 mg/l (21,163) versus 123 mg/l (70, 192) p = 0.008) and peak ferritin (229 μg/l (103, 551) versus 514 μg/l (228, 1122) p < 0.001). Using the Modified Lake-Louise criteria, females were more likely to have definite evidence of myocardial inflammation (54% (37/68) versus 33% (30/90) p = 0.003). At enrolment and 28–60 days post-discharge, enhanced illness perception, higher levels of anxiety and depression and lower predicted maximal oxygen utilization occurred more commonly in women. The mean (SD, range) duration of follow-up after hospital discharge was 450 (88) days (range 290, 627 days). Compared to men, women had lower rates of cardiovascular hospitalization (0% versus 8% (7/90); p = 0.018). Conclusions Women demonstrated worse patient reported outcome measures at index admission and 28–60 days follow-up though cardiovascular hospitalization was lower.
first_indexed 2024-03-09T15:29:49Z
format Article
id doaj.art-05e4dc91da864d5d8769af428b579857
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-03-09T15:29:49Z
publishDate 2023-08-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-05e4dc91da864d5d8769af428b5798572023-11-26T12:16:58ZengBMCBMC Cardiovascular Disorders1471-22612023-08-0123111310.1186/s12872-023-03412-7Post-COVID-19 illness and associations with sex and genderKenneth Mangion0Andrew J. Morrow1Robert Sykes2Anna Kamdar3Catherine Bagot4George Bruce5Paul Connelly6Christian Delles7Vivienne B. Gibson8Lynsey Gillespie9Pauline Hall Barrientos10Vera Lennie11Giles Roditi12Naveed Sattar13David Stobo14Sarah Allwood-Spiers15Alex McConnachie16Colin Berry17CISCO-19 investigatorsSchool of Cardiovascular and Metabolic Health, University of GlasgowSchool of Cardiovascular and Metabolic Health, University of GlasgowSchool of Cardiovascular and Metabolic Health, University of GlasgowSchool of Cardiovascular and Metabolic Health, University of GlasgowDepartment of Haemostasis and Thrombosis, Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde Health BoardDepartment of Medical Physics, NHS G Reater Glasgow and Clyde Health BoardSchool of Cardiovascular and Metabolic Health, University of GlasgowSchool of Cardiovascular and Metabolic Health, University of GlasgowDepartment of Haemostasis and Thrombosis, Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde Health BoardProject Management Unit, Glasgow Clinical Research Facility, NHS Greater Glasgow and Clyde Health BoardDepartment of Medical Physics, NHS G Reater Glasgow and Clyde Health BoardDepartment of Cardiology, Aberdeen Royal InfirmaryDepartment of Radiology, NHS Greater Glasgow and Clyde Health BoardSchool of Cardiovascular and Metabolic Health, University of GlasgowDepartment of Radiology, NHS Greater Glasgow and Clyde Health BoardDepartment of Medical Physics, NHS G Reater Glasgow and Clyde Health BoardRobertson Centre for Biostatistics, School of Health and Wellbeing, University of GlasgowSchool of Cardiovascular and Metabolic Health, University of GlasgowAbstract Background Post-COVID-19 syndromes have associated with female sex, but the pathophysiological basis is uncertain. Aim There are sex differences in myocardial inflammation identified using cardiac magnetic resonance (CMR) in post-COVID-19 patients, and in patient reported health outcomes following COVID-19 infection. Design This prospective study investigated the time-course of multiorgan injury in survivors of COVID-19 during convalescence. Methods Clinical information, blood biomarkers, and patient reported outcome measures were prospectively acquired at enrolment (visit 1) and 28–60 days post-discharge (visit 2). Chest computed tomography (CT) and CMR were performed at visit 2. Follow-up was carried out for serious adverse events, including death and rehospitalization. Results Sixty-nine (43%) of 159 patients recruited were female. During the index admission, females had a lower peak C-reactive protein (74 mg/l (21,163) versus 123 mg/l (70, 192) p = 0.008) and peak ferritin (229 μg/l (103, 551) versus 514 μg/l (228, 1122) p < 0.001). Using the Modified Lake-Louise criteria, females were more likely to have definite evidence of myocardial inflammation (54% (37/68) versus 33% (30/90) p = 0.003). At enrolment and 28–60 days post-discharge, enhanced illness perception, higher levels of anxiety and depression and lower predicted maximal oxygen utilization occurred more commonly in women. The mean (SD, range) duration of follow-up after hospital discharge was 450 (88) days (range 290, 627 days). Compared to men, women had lower rates of cardiovascular hospitalization (0% versus 8% (7/90); p = 0.018). Conclusions Women demonstrated worse patient reported outcome measures at index admission and 28–60 days follow-up though cardiovascular hospitalization was lower.https://doi.org/10.1186/s12872-023-03412-7COVID-19Severe acute respiratory syndrome coronavirus-19SARS CoV-2Female sexMale sexMyocarditis
spellingShingle Kenneth Mangion
Andrew J. Morrow
Robert Sykes
Anna Kamdar
Catherine Bagot
George Bruce
Paul Connelly
Christian Delles
Vivienne B. Gibson
Lynsey Gillespie
Pauline Hall Barrientos
Vera Lennie
Giles Roditi
Naveed Sattar
David Stobo
Sarah Allwood-Spiers
Alex McConnachie
Colin Berry
CISCO-19 investigators
Post-COVID-19 illness and associations with sex and gender
BMC Cardiovascular Disorders
COVID-19
Severe acute respiratory syndrome coronavirus-19
SARS CoV-2
Female sex
Male sex
Myocarditis
title Post-COVID-19 illness and associations with sex and gender
title_full Post-COVID-19 illness and associations with sex and gender
title_fullStr Post-COVID-19 illness and associations with sex and gender
title_full_unstemmed Post-COVID-19 illness and associations with sex and gender
title_short Post-COVID-19 illness and associations with sex and gender
title_sort post covid 19 illness and associations with sex and gender
topic COVID-19
Severe acute respiratory syndrome coronavirus-19
SARS CoV-2
Female sex
Male sex
Myocarditis
url https://doi.org/10.1186/s12872-023-03412-7
work_keys_str_mv AT kennethmangion postcovid19illnessandassociationswithsexandgender
AT andrewjmorrow postcovid19illnessandassociationswithsexandgender
AT robertsykes postcovid19illnessandassociationswithsexandgender
AT annakamdar postcovid19illnessandassociationswithsexandgender
AT catherinebagot postcovid19illnessandassociationswithsexandgender
AT georgebruce postcovid19illnessandassociationswithsexandgender
AT paulconnelly postcovid19illnessandassociationswithsexandgender
AT christiandelles postcovid19illnessandassociationswithsexandgender
AT viviennebgibson postcovid19illnessandassociationswithsexandgender
AT lynseygillespie postcovid19illnessandassociationswithsexandgender
AT paulinehallbarrientos postcovid19illnessandassociationswithsexandgender
AT veralennie postcovid19illnessandassociationswithsexandgender
AT gilesroditi postcovid19illnessandassociationswithsexandgender
AT naveedsattar postcovid19illnessandassociationswithsexandgender
AT davidstobo postcovid19illnessandassociationswithsexandgender
AT sarahallwoodspiers postcovid19illnessandassociationswithsexandgender
AT alexmcconnachie postcovid19illnessandassociationswithsexandgender
AT colinberry postcovid19illnessandassociationswithsexandgender
AT cisco19investigators postcovid19illnessandassociationswithsexandgender